
Thomas Cash MD , MSc
Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology
Associate Professor, Pediatrics, Emory University School of Medicine; Clinical Director of Solid Tumor Program, Aflac Cancer & Blood Disorders Center at Children's Healthcare of Atlanta
Join to View Full Profile
1405 Clifton Rd NEAtlanta, GA 30322
Phone+1 404-785-1112
Fax+1 404-785-6288
Dr. Cash is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2010 - 2013
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Pediatrics, 2007 - 2010
University of Alabama School of MedicineClass of 2007
Certifications & Licensure
GA State Medical License 2010 - 2028
AL State Medical License 1991 - 2016
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma Start of enrollment: 2021 Jun 09
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High-Risk Neuroblastoma: A Multi-Institutional Retrospective Study.Benjamin J Lerman, Madeleine King, Rajen Mody, Sara-Jane Onyeama, Araz Marachelian
Pediatric Blood & Cancer. 2026-05-01 - A Phase I Trial of Nab-Paclitaxel in Combination With Gemcitabine for Relapsed/Refractory Pediatric Solid Tumors.Jonathan Metts, Kevin Ginn, Zhulin He, Rohali Keesari, Jane C Cook
Pediatric Blood & Cancer. 2026-01-01 - Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From th...Mallory R Taylor, James R Anderson, Julie R Park, Meredith S Irwin, Mark A Applebaum
Pediatric Blood & Cancer. 2025-11-01
Press Mentions
- Georgia System Among 1st to Offer Y90 Liver Cancer Treatment to Pediatric PatientsMarch 27th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









